Author: Ellie Kincaid

Proceedings of the National Academy of Sciences has corrected an article by a prize-winning chemist following a report by Retraction Watch his threat to sue a fellow scientist who had submitted a letter to the journal critiquing the paper. 

Chad Mirkin, director of the International Institute for Nanotechnology at Northwestern University in Chicago, received one quarter of this year’s Kavli Prize in nanoscience for his work on spherical nucleic acids (SNAs), the topic of the PNAS article. 

As we reported last month, a lawyer representing Mirkin sent a cease and desist letter to Raphaël Lévy, a professor of physics at the Université Paris Sorbonne Nord, accusing Lévy of making “patently false and defamatory” statements about Mirkin’s research in a letter Lévy had submitted to PNAS about the now-corrected article. 

In his letter, Lévy wrote that the article’s “presentation of SNAs as a ‘powerful class of nanotherapeutics’ is misleading.” 

A Frontiers journal has taken down the abstract of a “provisionally accepted” article about harms from an herbal supplement after the company that sells the products sued the first author for defamation. 

The author of the paper, Cyriac Abby Philips, a hepatologist at Rajagiri Hospital in Kerala, India, has over 266,000 followers on his X account “TheLiverDoc.” In 2020, another of Philips’ papers about harm from supplements was retracted and removed after the large supplement company Herbalife, whose products the paper impugned, put legal pressure on Elsevier. 

Himalaya Wellness, an herbal supplement company which says its products are based on Ayurvedic practices, last year sued Philips for defamation based on his posts on X about the company’s products. 

One of the winners of the 2024 Kavli Prize in nanoscience has threatened to sue a longtime critic, Retraction Watch has learned. 

In a cease and desist letter, a lawyer representing Chad Mirkin, a chemist and director of the International Institute for Nanotechnology at Northwestern University in Chicago, accused Raphaël Lévy, a professor of physics at the Université Paris Sorbonne Nord, of making “patently false and defamatory” statements about Mirkin’s research.

The demand primarily concerns a letter to the editor Lévy submitted in April to Proceedings of the National Academy of Sciences regarding an article Mirkin co-authored, “Multimodal neuro-nanotechnology: Challenging the existing paradigm in glioblastoma therapy,” which appeared in the journal in February. 

The recent criminal indictment of a medical school professor and former scientific advisor to Cassava Sciences on fraud charges for manipulating images in scientific papers and applications for federal funding is a “rare” outcome for such alleged actions that “sends a very, very powerful message.” 

That’s according to lawyers who have worked on research misconduct cases. 

While many investigations by the U.S. Office of Research Integrity and other government watchdogs find scientists manipulated data in grant applications to the National Institutes of Health and National Science Foundation, few are charged with “major fraud against the United States,” as was Hoau-yan Wang.